coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Alps Group PCN, Eastbourne · Health Inequalities Profile

    PCN U52868 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    53,976

    Registered population

    57.3% aged 18–64

    24.9%

    Aged 65+

    ICB 21.9% · England 17.9%

    2.4%

    Ethnic minority (non-White)

    1.4% Asian · England 9.6%

    24.8%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~12,832

    Core20 residents (est.)

    Resident basis; registered basis ~13,429 · see page 3

    10,306

    Hypertension register

    +4.29% in 3 yrs · England +5.60%

    876

    SMI register

    54.1% of Eastbourne's

    1,395

    COPD register

    Reviews -1.90% in 3 yrs

    Forecast to 2030

    11,844

    Hypertension patients, 2030

    +1,538 on today

    68.8%

    QRISK ≥20% on statins, 2030

    +3.55pp over 3 yrs

    6.3%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    57.9%
    Under-80 BP control fell behind England.

    Under-80 hypertension BP control fell 5.6% over three years to 57.9%, sitting 10.0 percentage points below England (67.8%, +3.2%).

    67.0%
    SMI physical health checks lag England.

    Annual SMI checks trail England across BMI recording at 67.0% (England 82.1%), alcohol recording at 68.1% (81.8%) and BP checks at 72.4% (83.4%).

    +13.0%
    Three-year asthma review growth outpaced England.

    Recorded 12-month asthma reviews rose +13.0% (+5.7 pp) over three years against England's +4.4% (+2.8 pp), though coverage remains 49.7% (England 65.7%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Aged 65+ patients comprise 24.9% of the list, 7.0 percentage points above England

    ALPS GROUP PCN registers 53,976 patients across four practices. Patients aged 65+ comprise 24.9% (13,441), above Eastbourne (24.2%), NHS Sussex Integrated Care Board (21.9%) and England (17.9%). The 18–64 band represents 57.3% (Eastbourne 58.6%, NHS Sussex Integrated Care Board 60.5%, England 62.7%) and ages 0–17 represent 17.8% (Eastbourne 17.2%, NHS Sussex Integrated Care Board 17.7%, England 19.6%). List growth to 2030 is projected at 3.0% (Eastbourne 1.1%, NHS Sussex Integrated Care Board 2.1%, England 2.3%; unverified methodology). Census area estimates show 97.6% White and 2.4% ethnic minorities; Census resident bases differ from registered lists.

    Age profile

    0–1717.8%
    18–6457.3%
    65+24.9%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White97.6%
    Asian1.4%
    Black0.5%
    Mixed0.4%
    Other0.2%

    Older people · falls rows are Eastbourne local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Eastbourne LA)2,3252,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)79.6%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.4%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Eastbourne LA)1,2219819552024/25
    Falls deaths, all ages, per 100,000 (Eastbourne LA)7.714.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation affects 24.8% of patients and spans 31.2 percentage points across practices

    Core20 patients represent 24.8% of the PCN list, above Eastbourne (19.5%), NHS Sussex Integrated Care Board (9.2%) and England (21.0%). Practice rates span 31.2 percentage points, from 6.0% at Arlington Road Surgery to 37.2% at Seaside Medical Centre. Three practices exceed England: Seaside Medical Centre holds the highest concentration (37.2%, 4,314 patients) while Park Practice holds the largest volume (34.4%, 4,548 patients). Modelled practice estimates do not sum to the 12,832 resident estimate. Targeted outreach could address concentrated deprivation at the two leading practices first.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Seaside37.2% · 4,314 patients
    Park34.4% · 4,548 patients
    Lighthouse22.4% · 3,847 patients
    Arlington Road6.0% · 720 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    876

    SMI register

    1.59% recorded prevalence

    518

    Learning disability register

    0.94% recorded prevalence

    70

    Care homes, 2,193 beds

    In the PCN catchment

    9.7%

    Provide unpaid care

    Eastbourne, Census 2021

    The PCN records 876 severe mental illness patients (1.6%; Eastbourne 1.5%, NHS Sussex Integrated Care Board 1.1%, England 1.0%) and 518 on learning disability (0.9%; Eastbourne 0.8%, NHS Sussex Integrated Care Board 0.6%, England 0.6%). Catchment care homes comprise 70 sites with 2,193 beds.

    Severe mental illness: physical health checks

    Recorded severe mental illness prevalence is 1.6% (England 1.0%). Annual physical checks trail England: blood pressure recording is 72.4% (England 83.4%) and BMI recording is 67.0% (England 82.1%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    10,306

    Hypertension register

    +4.29%

    Register growth, 3 yrs

    Eastbourne +5.24% · England +5.60%

    −3.45pp

    BP control, under 80

    ≤140/90 · −0.30pp aged 80+

    +1,538

    More patients by 2030

    Forecast 11,844 (20.35%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 18.7% (10,306 patients), above Eastbourne (17.5%), NHS Sussex Integrated Care Board (16.3%) and England (15.2%). While 85.7% of patients have a recent blood pressure reading (England 90.0%), control in patients aged under 80 fell 5.6% over three years to 57.9%, trailing Eastbourne (60.5%), the ICB (66.8%) and England (67.8%, which rose +3.2%). Control for aged 80 and over also trails at 75.5% (England 81.2%). This widening control shortfall despite high monitoring could reflect delays in treatment titration, which a local clinical audit would test. Under-80 blood pressure control is well below national and system comparators, meaning the PCN should prioritise structured medication titration and follow-up across its recorded hypertensive cohort.

    Lipids and statins

    Lipid-lowering therapy reaches 61.0% of patients with QRISK ≥ 20%, below England (63.6%) but above NHS Sussex Integrated Care Board (60.0%), while treatment among CKD patients is 63.9% (England 70.3%). Fewer high-risk primary prevention and CKD patients receive lipid therapy than nationally, indicating an opportunity to prioritise systematic recall and initiation.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026103,578£2.20£2.42£1.86£227,872
    Cardiovascular (all), 2025149,841£3.05£3.32£3.33£457,015

    In 2026, the PCN prescribed 103,578 lipid-regulating items at £2.20 per item (spend £227,872), compared with £1.86 in England and £2.42 in NHS Sussex Integrated Care Board. This was £35,217 more than at England's unit cost. Higher unit costs than England indicate potential scope to review lipid-modifying formulary choices while sustaining treatment reach.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +13.00%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.38%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.6% (3,996 patients) against 6.6% in England, with asthma prescribing at 1,973 items per 1,000 aged 5–19 (England 1,488). Despite a +13.0% (+5.7 pp) three-year rise, only 49.7% of asthma patients had a 12-month review (England 65.7%), leaving an unreviewed scale gap of about 2,000 patients. COPD prevalence is 2.5% (England 1.9%), yet 12-month reviews reach 68.4% (England 76.4%). Slower review delivery alongside higher prescribing could reflect follow-up capacity constraints, which local audit would test.

    Cancer register and children's immunisation

    Recorded cancer prevalence is 5.6% (3,059 patients; England 3.8%). In childhood immunisation, MMR dose 1 coverage at 24 months is 86.4% (England 88.3%, NHS Sussex ICB 90.2%), falling 8.6 pp below the 95.0% target. At age 5, PCN coverage is 93.7% for MMR dose 1 but 87.4% for MMR dose 2 (a 6.3 pp gap).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.2%

    England 91.0%

    6-in-1 complete primary course at 24 months91.4%

    England 92.2%

    MMR dose 1 at 24 months86.4%

    England 88.3%

    MMR dose 2 at age 587.4%

    England 82.8%

    4-in-1 pre-school booster at age 587.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In 2022, NHS Sussex ICB diagnosed 58.5% of staged cancers at stage 1 or 2 (England 55.3%), sitting 16.5 pp below the 75.0% national ambition by 2028, with known-stage completeness at 64.3% across 12,766 registered cases. These system figures do not measure PCN performance. At PCN level, cervical screening coverage at ages 25-49 is 65.7% (England 66.8%, NHS Sussex Integrated Care Board 68.6%), falling 5.0% over three years (England -1.0%), and reaching 61.1% at The Lighthouse Medical Practice. Breast screening coverage trails at 67.1% (England 69.9%). Primary care screening recall remains central to earlier detection.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional Jul 2026 data, East Sussex Healthcare NHS Trust met the 28-day faster diagnosis standard at 84.2% (standard 75.0%; Maidstone and Tunbridge Wells NHS Trust 81.8%, England 79.3%, University Hospitals Sussex NHS Foundation Trust 74.0%) and 31-day treatment at 98.2% (standard 96.0%). However, 62-day treatment reached 67.0%, below the 85.0% standard, England (71.2%) and NHS Surrey and Sussex Integrated Care Board (71.5%). Diagnostic 6+ week waits across all diagnostic tests stood at 5.3% (England 23.1%), while echocardiography was 21.9%. These provider figures reflect acute pressure rather than PCN-specific pathways.

    Pathways within standard (%)East Sussex HealthcareSussexMaidstone and Tunbridge WellsSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)84.2074.0181.7879.2979.32
    31-day treatment (96%)98.1976.7998.3590.4592.50
    62-day referral to treatment (85%)67.0465.2087.4371.5171.16
    Diagnostic waits over 6 weeks (%)East Sussex HealthcareSussexMaidstone and Tunbridge WellsEngland
    MRI6.485.620.9221.40
    CT0.488.570.519.92
    Echocardiography21.940.392.5728.48
    Colonoscopy0.7439.3519.8030.83
    Gastroscopy0.3120.0224.0329.02
    All 15 DM01 tests5.2712.956.4223.14
    Community services activityEast Sussex residentsSurrey and Sussex ICB
    Care contacts100,740309,615
    Referrals17,28566,930
    Patients with a contact25,88085,660

    Community services (residents of East Sussex), Jun 2026 (provisional). In Jun 2026 (provisional), contacts with adults aged 65+ accounted for 68% of Eastbourne residents' community health service contacts (68,465 of 100,740). This borough-level activity reflects resident use rather than registered PCN patients. Coordinated primary and community care remains vital for older patients.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    Clinical QOF achievement reaches 99.2% to 100.0% across all four practices (England 97.1%). In vaccination, Arlington Road Surgery reached 36.6% (England 55.2%) while Seaside Medical Centre reached 100.0%, a 63.4 pp range. All-domain personalised care adjustments span 10.5% at Arlington Road Surgery to 14.0% at Seaside Medical Centre (England 10.0%), which may indicate that high points mask delivery variation.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Seaside9737.261.0%72.2%92.5%
    Arlington Road1316.071.9%80.6%87.5%
    Park Practice9534.427.4%71.4%72.6%
    Lighthouse11122.443.6%64.6%70.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNEastbourneAssetPCNEastbourne
    Care homes (catchment)70 (2,193 beds)n/aSchools (catchment)67n/a
    Children's centres22Places of worship5546
    Libraries33Homelessness support (VCS)0no data
    Day centres (VCS)11Carers support groups (VCS)11
    Primary schools (LA maintained)108Primary academies2122
    Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review recall

    On the 3,996 asthma register, 49.7% had a 12-month review (Eastbourne 52.3%, ICB 62.5%, England 65.7%), a scale gap of about 2,000 patients despite a +13.0% (+5.7 pp) three-year rise. For discussion: the PCN could run structured asthma recall using a single review template at Core20-concentrated practices first. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Under-80 hypertension titration review

    Among 10,306 hypertension patients (18.7%), under-80 blood pressure control (<= 140/90 mmHg) fell 5.6% (3.5 pp) over three years to 57.9%, trailing Eastbourne (60.5%), ICB (66.8%) and England (67.8%). For discussion: the PCN could run pharmacist-led or nurse-led titration clinics for registered under-80 patients above target. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Combined SMI physical health checks

    Across 876 SMI patients (1.6%; 54.1% of Eastbourne's register), 12-month BMI recording is 67.0% (England 82.1%), alcohol recording 68.1% (England 81.8%) and BP checks 72.4% (England 83.4%). For discussion: practices could book combined physical check appointments, audit partial-check coding, and raise shared recording pathways with mental health partners. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult service planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 clinical outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall audit (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension treatment titration audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool booster and MMR recall (p6)MMR dose 1 coverage at 24 months10YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Under-80 hypertension titration review (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Combined SMI physical health checks (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15